Search alternatives:
significantly mediated » significantly predicted (Expand Search), significantly related (Expand Search), significantly reduced (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
mediated decrease » mediated defense (Expand Search), estimated decrease (Expand Search), mediated diseases (Expand Search)
decrease reversal » increases reversal (Expand Search)
Showing 121 - 140 results of 11,270 for search '(( significantly mediated decrease ) OR ( significant decrease reversal ))', query time: 0.52s Refine Results
  1. 121
    Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF

    Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  2. 122
    Image_2_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF

    Image_2_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIFF by Rohit Moudgil (540119)

    Published 2020
    Save to List
    Saved in:
  3. 123
    Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats.

    Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 124
    Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i>

    Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i> by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 125
    Summary of cell-based assay EC50 results for WT BMP9 and A347E variant.

    Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 126
    Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode.

    Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 127
    Hemodynamic effects of WT BMP9 in rats.

    Hemodynamic effects of WT BMP9 in rats. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 128
    Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode.

    Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 129
    <i>In vivo</i> PK evaluation of WT BMP9 in naïve SD rats.

    <i>In vivo</i> PK evaluation of WT BMP9 in naïve SD rats. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 130
    Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i>

    Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i> by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 131
    Characterization of safety pharmacology of WT BMP9 in rats.

    Characterization of safety pharmacology of WT BMP9 in rats. by Tobias G. Schips (21799838)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 132
    hsa-let-7e-5p acts as a downstream mediator of circ_0000006 and circ_0000160.

    hsa-let-7e-5p acts as a downstream mediator of circ_0000006 and circ_0000160. by Yong Liu (6908)

    Published 2024
    Save to List
    Saved in:
  13. 133
    List of 421 genes whose expression is increased by galactose and decreased by any of the HAT inhibitors.

    List of 421 genes whose expression is increased by galactose and decreased by any of the HAT inhibitors. by Masaya Nagaya (13851123)

    Published 2022
    Save to List
    Saved in:
  14. 134
    List of 412 genes whose expression is decreased by galactose and increased by any of the HAT inhibitors.

    List of 412 genes whose expression is decreased by galactose and increased by any of the HAT inhibitors. by Masaya Nagaya (13851123)

    Published 2022
    Save to List
    Saved in:
  15. 135
    Knockdown of MRN complex decreases HBV cccDNA level.

    Knockdown of MRN complex decreases HBV cccDNA level. by Kaitao Zhao (3617825)

    Published 2025
    Save to List
    Saved in:
  16. 136
    Knockdown of MRN complex decreases HBV cccDNA level.

    Knockdown of MRN complex decreases HBV cccDNA level. by Kaitao Zhao (3617825)

    Published 2025
    Save to List
    Saved in:
  17. 137
    Schematic diagram of engine reversed towing experiment device.

    Schematic diagram of engine reversed towing experiment device. by Xin Kuang (17390340)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 138
    B lymphocytes in splenic germinal centers significantly depleted in BLyS<sup>-/-</sup>.

    B lymphocytes in splenic germinal centers significantly depleted in BLyS<sup>-/-</sup>. by Natalie M. Bath (6316517)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 139
    Tumor development leads to decreased visceral adipose tissue weight in obese mice but not in lean mice.

    Tumor development leads to decreased visceral adipose tissue weight in obese mice but not in lean mice. by Aleida Núñez-Ruiz (12463062)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 140
    Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.

    Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

    Published 2025
    Save to List
    Saved in:

Search Tools: